In the last 12 months, insiders at CVS HEALTH Corp ($CVS) filed 184 transactions with the SEC: 8 open-market purchases totaling $2,661,059 and 9 sales totaling $256,994,498. Net insider sentiment: net selling.
CVS HEALTH Corp operates in the Retail-drug stores and proprietary stores industry (Trade & services sector).
Most Active Insiders
- ROBBINS LARRY (Not found) — 6 transactions totaling $253,695,413
- Lynch Karen S (President and CEO) — 4 transactions totaling $8,528,991
- CAPOZZI HEIDI B (EVP and Chief People Officer) — 10 transactions totaling $7,382,412
- Joyner J. David (President, CEO and Chair) — 2 transactions totaling $6,781,956
- Shah Prem S (EVP and Group President) — 11 transactions totaling $4,380,738
View all SEC Filings for CVS HEALTH Corp (CVS).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Khichi Samrat S. | EVP, CPO and General Counsel | A | Stock Option | 80838 | $71.82 | 80,838.0000 | 1,271,000,000 | 9999.99% | 0.01% |
| March 31, 2026 | Khichi Samrat S. | EVP, CPO and General Counsel | A | Common Stock (Restricted) | 12531 | $71.82 | 38,139.0000 | 1,271,000,000 | 48.93% | 0.00% |
| March 31, 2026 | Clark James David | SVP, Cont & Chief Acct Officer | A | Stock Option | 11976 | $71.82 | 11,976.0000 | 1,271,000,000 | 9999.99% | 0.00% |
| April 1, 2026 | Clark James David | SVP, Cont & Chief Acct Officer | F | Common Stock | 3262 | $72.49 | 15,457.0000 | 1,271,000,000 | 17.43% | 0.00% |
| March 31, 2026 | Clark James David | SVP, Cont & Chief Acct Officer | A | Common Stock (Restricted) | 11138 | $71.82 | 35,539.0000 | 1,271,000,000 | 45.65% | 0.00% |
| March 31, 2026 | Compton-Phillips Amy | EVP, Chief Medical Officer | A | Stock Option | 35928 | $71.82 | 35,928.0000 | 1,271,000,000 | 9999.99% | 0.00% |
| March 31, 2026 | Compton-Phillips Amy | EVP, Chief Medical Officer | A | Common Stock (RSUs) | 5569 | $71.82 | 58,660.0000 | 1,271,000,000 | 10.49% | 0.00% |
| April 1, 2026 | Joyner J. David | President, CEO and Chair | F | Common Stock | 8029 | $72.49 | 70,349.0000 | 1,271,000,000 | 10.24% | 0.00% |
| March 31, 2026 | Joyner J. David | President, CEO and Chair | A | Common Stock (RSUs) | 86326 | $71.82 | 160,860.0000 | 1,271,000,000 | 115.82% | 0.01% |
| April 1, 2026 | Khichi Samrat S. | EVP, CPO and General Counsel | F | Common Stock | 3541 | $72.49 | 33,421.0000 | 1,271,000,000 | 9.58% | 0.00% |
| March 31, 2026 | CAPOZZI HEIDI B | EVP and Chief People Officer | A | Common Stock (Restricted) | 10025 | $71.82 | 84,450.0000 | 1,271,000,000 | 13.47% | 0.00% |
| April 1, 2026 | CAPOZZI HEIDI B | EVP and Chief People Officer | F | Common Stock | 1334 | $72.49 | 13,023.0000 | 1,271,000,000 | 9.29% | 0.00% |
| March 31, 2026 | CAPOZZI HEIDI B | EVP and Chief People Officer | A | Stock Option | 64670 | $71.82 | 64,670.0000 | 1,271,000,000 | 9999.99% | 0.01% |
| March 31, 2026 | Shah Prem S | EVP and Group President | A | Common Stock (Restricted) | 25062 | $71.82 | 62,852.0000 | 1,271,000,000 | 66.32% | 0.00% |
| April 1, 2026 | Shah Prem S | EVP and Group President | F | Common Stock | 1484 | $72.49 | 64,356.0985 | 1,271,000,000 | 2.25% | 0.00% |
| March 31, 2026 | Shah Prem S | EVP and Group President | A | Stock Option | 161676 | $71.82 | 161,676.0000 | 1,271,000,000 | 9999.99% | 0.01% |
| March 31, 2026 | Newman Brian | EVP, Chief Financial Officer | A | Common Stock (RSUs) | 19493 | $71.82 | 41,354.0000 | 1,271,000,000 | 89.17% | 0.00% |
| March 31, 2026 | Newman Brian | EVP, Chief Financial Officer | A | Stock Option | 125748 | $71.82 | 125,748.0000 | 1,271,000,000 | 9999.99% | 0.01% |
| March 31, 2026 | Nelson Steven H | EVP and President, Aetna | A | Common Stock (Restricted) | 22277 | $71.82 | 43,606.0000 | 1,271,000,000 | 104.44% | 0.00% |
| April 1, 2026 | Nelson Steven H | EVP and President, Aetna | F | Common Stock | 2432 | $72.49 | 2,900.0000 | 1,271,000,000 | 45.61% | 0.00% |
| March 31, 2026 | Nelson Steven H | EVP and President, Aetna | A | Stock Option | 143712 | $71.82 | 143,712.0000 | 1,271,000,000 | 9999.99% | 0.01% |
| March 31, 2026 | Mandadi Tilak | EVP, Chief Exp & Tech Officer | A | Common Stock (RSUs) | 22277 | $71.82 | 88,543.0000 | 1,271,000,000 | 33.62% | 0.00% |
| April 1, 2026 | Mandadi Tilak | EVP, Chief Exp & Tech Officer | F | Common Stock | 3634 | $72.49 | 79,684.0000 | 1,271,000,000 | 4.36% | 0.00% |
| March 31, 2026 | Mandadi Tilak | EVP, Chief Exp & Tech Officer | A | Stock Option | 143712 | $71.82 | 143,712.0000 | 1,271,000,000 | 9999.99% | 0.01% |
| March 19, 2026 | Gallina John E | Director | A | Common Stock | 582 | $71.86 | 582.0000 | 1,271,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2026 | Khichi Samrat S. | EVP, CPO and General Counsel | F | Common Stock | 7886 | $79.60 | 29,775.0000 | 1,271,000,000 | 20.94% | 0.00% |
| Feb. 28, 2026 | Joyner J. David | President and CEO | F | Common Stock | 1944 | $79.90 | 49,996.0000 | 1,271,000,000 | 3.74% | 0.00% |
| Jan. 23, 2025 | Nelson Steven H | EVP and President, Aetna | P | Common Stock (By Trust) | 24 | $53.70 | 24.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| Jan. 1, 2026 | Shah Prem S | EVP and Group President | F | Common Stock | 247 | $80.13 | 61,509.3235 | 1,271,000,000 | 0.40% | 0.00% |
| Nov. 30, 2025 | Mandadi Tilak | EVP, Chief Exp & Tech Officer | F | Common Stock | 6575 | $80.36 | 74,085.0000 | 1,269,000,000 | 8.15% | 0.00% |
| Nov. 30, 2025 | CAPOZZI HEIDI B | EVP and Chief People Officer | F | Common Stock | 9470 | $80.36 | 11,415.0000 | 1,269,000,000 | 45.34% | 0.00% |
| Nov. 30, 2025 | FARAH ROGER N | Director | F | Common Stock | 9748 | $80.36 | 19,438.4534 | 1,269,000,000 | 33.40% | 0.00% |
| Dec. 1, 2025 | Clark James David | SVP, Cont & Chief Acct Officer | F | Common Stock (Restricted) | 220 | $79.10 | 24,401.0000 | 1,269,000,000 | 0.89% | 0.00% |
| Nov. 20, 2025 | Finucane Anne A. | Director | A | Deferred Stock Units | 1775 | $76.04 | 16,530.0615 | 1,269,000,000 | 12.03% | 0.00% |
| Nov. 20, 2025 | AGUIRRE FERNANDO | Director | A | Common Stock | 1800 | $76.04 | 40,950.0000 | 1,269,000,000 | 4.60% | 0.00% |
| Nov. 20, 2025 | Balser Jeffrey R. | Director | A | Common Stock | 1775 | $76.04 | 13,659.0000 | 1,269,000,000 | 14.94% | 0.00% |
| Nov. 20, 2025 | BROWN C DAVID II | Director | A | Common Stock | 1775 | $76.04 | 127,772.0000 | 1,269,000,000 | 1.41% | 0.00% |
| Nov. 20, 2025 | DECOUDREAUX ALECIA A | Director | A | Deferred Stock Units | 1652 | $76.04 | 40,053.5157 | 1,269,000,000 | 4.30% | 0.00% |
| Nov. 20, 2025 | Finucane Anne A. | Director | A | Common Stock | 591 | $76.04 | 591.0000 | 1,269,000,000 | 9999.99% | 0.00% |
| Nov. 20, 2025 | KIRBY J SCOTT | Director | A | Common Stock | 1652 | $76.04 | 12,987.0000 | 1,269,000,000 | 14.57% | 0.00% |
| Nov. 20, 2025 | Mahoney Michael F | Director | A | Deferred Stock Units | 2022 | $76.04 | 4,613.3964 | 1,269,000,000 | 78.02% | 0.00% |
| Nov. 20, 2025 | Norwalk Leslie V | Director | A | Common Stock | 1652 | $76.04 | 5,929.0000 | 1,269,000,000 | 38.63% | 0.00% |
| Nov. 20, 2025 | ROBBINS LARRY | Director | A | Deferred Stock Units | 2203 | $76.04 | 8,080.2915 | 1,269,000,000 | 37.48% | 0.00% |
| Nov. 20, 2025 | SANSONE GUY P | Director | A | Common Stock | 1652 | $76.04 | 13,659.3550 | 1,269,000,000 | 13.76% | 0.00% |
| Nov. 20, 2025 | Shulman Douglas H. | Director | A | Common Stock | 1652 | $76.04 | 5,929.0000 | 1,269,000,000 | 38.63% | 0.00% |
| Oct. 2, 2024 | CAPOZZI HEIDI B | EVP and Chief People Officer | P | Common Stock | 10 | $62.24 | 50.0000 | 1,262,000,000 | 25.00% | 0.00% |
| Oct. 23, 2024 | CAPOZZI HEIDI B | EVP and Chief People Officer | P | Common Stock | 35 | $56.85 | 85.0000 | 1,262,000,000 | 70.00% | 0.00% |
| Sept. 9, 2024 | CAPOZZI HEIDI B | EVP and Chief People Officer | P | Common Stock | 35 | $56.47 | 40.0000 | 1,290,000,000 | 700.00% | 0.00% |
| Aug. 31, 2025 | Shah Prem S | EVP and Group President | F | Common Stock | 6995 | $73.15 | 60,631.6770 | 1,262,000,000 | 10.34% | 0.00% |
| Aug. 31, 2025 | Mandadi Tilak | EVP, Chief Exp & Tech Officer | F | Common Stock | 12834 | $73.15 | 63,952.0000 | 1,262,000,000 | 16.71% | 0.00% |
| Aug. 20, 2025 | Finucane Anne A. | Director | S | Common Stock | 7500 | $71.02 | 22,156.0000 | 1,262,000,000 | 25.29% | 0.00% |
| June 5, 2025 | SANSONE GUY P | Director | P | Common Stock | 1570 | $63.70 | 12,007.3550 | 1,262,000,000 | 15.04% | 0.00% |
| May 31, 2025 | Newman Brian | EVP, Chief Financial Officer | A | Common Stock (RSUs) | 21861 | $64.04 | 21,861.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| May 31, 2025 | Compton-Phillips Amy | EVP, Chief Medical Officer | A | Common Stock (RSUs) | 46845 | $64.04 | 46,845.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| May 31, 2025 | Newman Brian | EVP, Chief Financial Officer | A | Stock Option | 94786 | $0.00 | 94,786.0000 | 1,262,000,000 | 9999.99% | 0.01% |
| May 31, 2025 | Compton-Phillips Amy | EVP, Chief Medical Officer | A | Common Stock (RSUs) | 6246 | $64.04 | 53,091.0000 | 1,262,000,000 | 13.33% | 0.00% |
| May 31, 2025 | Compton-Phillips Amy | EVP, Chief Medical Officer | A | Stock Option | 27081 | $0.00 | 27,081.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| May 15, 2025 | DECOUDREAUX ALECIA A | Director | A | Deferred Stock Units | 2077 | $60.47 | 37,765.4382 | 1,262,000,000 | 5.82% | 0.00% |
| May 15, 2025 | Finucane Anne A. | Director | A | Common Stock | 692 | $60.47 | 692.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| May 15, 2025 | KIRBY J SCOTT | Director | A | Common Stock | 2769 | $60.47 | 11,335.0000 | 1,262,000,000 | 32.33% | 0.00% |
| May 15, 2025 | Mahoney Michael F | Director | A | Deferred Stock Units | 2543 | $60.47 | 2,542.5831 | 1,262,000,000 | 9999.99% | 0.00% |
| May 15, 2025 | Mahoney Michael F | Director | A | Common Stock | 144 | $60.47 | 6,345.0000 | 1,262,000,000 | 2.32% | 0.00% |
| May 15, 2025 | Norwalk Leslie V | Director | A | Common Stock | 2077 | $60.47 | 4,277.0000 | 1,262,000,000 | 94.41% | 0.00% |
| May 15, 2025 | ROBBINS LARRY | Director | A | Deferred Stock Units | 2770 | $60.47 | 5,766.7068 | 1,262,000,000 | 92.43% | 0.00% |
| May 15, 2025 | SANSONE GUY P | Director | A | Common Stock | 2077 | $60.47 | 10,437.3550 | 1,262,000,000 | 24.84% | 0.00% |
| May 15, 2025 | Shulman Douglas H. | Director | A | Common Stock | 2077 | $60.47 | 4,277.0000 | 1,262,000,000 | 94.41% | 0.00% |
| May 15, 2025 | Finucane Anne A. | Director | A | Deferred Stock Units | 2077 | $60.47 | 14,513.2718 | 1,262,000,000 | 16.71% | 0.00% |
| May 15, 2025 | AGUIRRE FERNANDO | Director | A | Common Stock | 2263 | $60.47 | 39,150.0000 | 1,262,000,000 | 6.13% | 0.00% |
| May 15, 2025 | Balser Jeffrey R. | Director | A | Common Stock | 2232 | $60.47 | 11,884.0000 | 1,262,000,000 | 23.12% | 0.00% |
| May 15, 2025 | BROWN C DAVID II | Director | A | Common Stock | 2232 | $60.47 | 125,997.0000 | 1,262,000,000 | 1.80% | 0.00% |
| April 1, 2025 | Joyner J. David | President and CEO | A | Common Stock (RSUs) | 53324 | $0.00 | 82,515.0000 | 1,262,000,000 | 182.67% | 0.00% |
| May 5, 2025 | ROBBINS LARRY | Not found | S | Common Stock | 96999 | $67.99 | 8,346,799.0000 | 1,262,000,000 | 1.15% | 0.01% |
| May 2, 2025 | ROBBINS LARRY | Not found | S | Common Stock | 1679736 | $67.39 | 10,267,063.0000 | 1,262,000,000 | 14.06% | 0.13% |
| May 2, 2025 | ROBBINS LARRY | Not found | S | Common Stock | 222556 | $68.38 | 10,044,507.0000 | 1,262,000,000 | 2.17% | 0.02% |
| May 2, 2025 | ROBBINS LARRY | Not found | S | Common Stock | 373776 | $69.66 | 9,670,731.0000 | 1,262,000,000 | 3.72% | 0.03% |
| May 5, 2025 | ROBBINS LARRY | Not found | S | Common Stock | 1226933 | $67.37 | 8,443,798.0000 | 1,262,000,000 | 12.69% | 0.10% |
| May 6, 2025 | ROBBINS LARRY | Not found | S | Common Stock | 150000 | $66.67 | 8,196,799.0000 | 1,262,000,000 | 1.80% | 0.01% |
| April 1, 2025 | Shah Prem S | EVP and Group President | F | Common Stock | 1308 | $67.98 | 47,250.6770 | 1,262,000,000 | 2.69% | 0.00% |
| April 1, 2025 | Joyner J. David | President and CEO | F | Common Stock | 1847 | $67.98 | 51,940.0000 | 1,262,000,000 | 3.43% | 0.00% |
| April 1, 2025 | Shah Prem S | EVP and Group President | A | Stock Option | 112289 | $67.98 | 112,289.0000 | 1,262,000,000 | 9999.99% | 0.01% |
| April 1, 2025 | Nelson Steven H | EVP and President, Aetna | A | Common Stock (Restricted) | 21329 | $67.98 | 21,329.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| April 1, 2025 | Nelson Steven H | EVP and President, Aetna | A | Stock Option | 90455 | $67.98 | 90,455.0000 | 1,262,000,000 | 9999.99% | 0.01% |
| April 1, 2025 | Shah Prem S | EVP and Group President | A | Common Stock (Restricted) | 26478 | $67.98 | 58,166.0000 | 1,262,000,000 | 83.56% | 0.00% |
| April 1, 2025 | Mandadi Tilak | EVP, Chief Experience & Tech | F | Common Stock | 995 | $67.98 | 43,503.0000 | 1,262,000,000 | 2.24% | 0.00% |
| April 1, 2025 | Mandadi Tilak | EVP, Chief Experience & Tech | A | Common Stock (RSU) | 20594 | $67.98 | 116,257.0000 | 1,262,000,000 | 21.53% | 0.00% |
| April 1, 2025 | Mandadi Tilak | EVP, Chief Experience & Tech | A | Stock Option | 87336 | $67.98 | 87,336.0000 | 1,262,000,000 | 9999.99% | 0.01% |
| April 1, 2025 | Khichi Samrat S. | EVP, CPO and General Counsel | F | Common Stock | 1548 | $67.98 | 21,700.0000 | 1,262,000,000 | 6.66% | 0.00% |
| April 1, 2025 | Khichi Samrat S. | EVP, CPO and General Counsel | A | Common Stock (Restricted) | 16181 | $67.98 | 41,569.0000 | 1,262,000,000 | 63.73% | 0.00% |
| April 1, 2025 | Khichi Samrat S. | EVP, CPO and General Counsel | A | Stock Option | 68621 | $67.98 | 68,621.0000 | 1,262,000,000 | 9999.99% | 0.01% |
| April 1, 2025 | COWHEY THOMAS F. | EVP and CFO | F | Common Stock | 3203 | $67.98 | 50,188.0000 | 1,262,000,000 | 6.00% | 0.00% |
| April 1, 2025 | COWHEY THOMAS F. | EVP and CFO | A | Common Stock (Restricted) | 16181 | $67.98 | 41,109.0000 | 1,262,000,000 | 64.91% | 0.00% |
| April 1, 2025 | COWHEY THOMAS F. | EVP and CFO | A | Stock Option | 68621 | $67.98 | 68,621.0000 | 1,262,000,000 | 9999.99% | 0.01% |
| April 1, 2025 | Clark James David | SVP, Cont & Chief Acct Officer | F | Common Stock | 2266 | $67.98 | 11,240.0000 | 1,262,000,000 | 16.78% | 0.00% |
| April 1, 2025 | Clark James David | SVP, Cont & Chief Acct Officer | A | Common Stock (Restricted) | 14710 | $67.98 | 24,707.0000 | 1,262,000,000 | 147.14% | 0.00% |
| April 1, 2025 | CAPOZZI HEIDI B | EVP and Chief People Officer | A | Common Stock (Restricted) | 11768 | $67.98 | 95,310.0000 | 1,262,000,000 | 14.09% | 0.00% |
| April 1, 2025 | CAPOZZI HEIDI B | EVP and Chief People Officer | A | Stock Option | 49906 | $67.98 | 49,906.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| April 1, 2025 | Joyner J. David | President and CEO | A | Stock Option | 226138 | $67.98 | 226,138.0000 | 1,262,000,000 | 9999.99% | 0.02% |
| March 17, 2025 | Shah Prem S | EVP and Group President | M | Stock Option | 846 | $0.00 | 0.0000 | 1,262,000,000 | 100.00% | 0.00% |
| March 17, 2025 | Shah Prem S | EVP and Group President | M | Common Stock | 846 | $62.21 | 43,189.6770 | 1,262,000,000 | 2.00% | 0.00% |
| Nov. 18, 2022 | Finucane Anne A. | Director | G | Common Stock | 800 | $97.35 | 28,964.0000 | 0 | 2.69% | 0.00% |
| March 5, 2025 | Clark James David | SVP, Cont & Chief Acct Officer | M | Common Stock | 7513 | $62.21 | 15,907.0000 | 1,262,000,000 | 89.50% | 0.00% |
| March 5, 2025 | Clark James David | SVP, Cont & Chief Acct Officer | S | Common Stock | 7513 | $66.35 | 8,394.0000 | 1,262,000,000 | 47.23% | 0.00% |
| March 5, 2025 | Clark James David | SVP, Cont & Chief Acct Officer | M | Stock Option | 7513 | $0.00 | 0.0000 | 1,262,000,000 | 100.00% | 0.00% |
| Feb. 28, 2025 | Joyner J. David | President and CEO | F | Common Stock | 1944 | $65.72 | 46,717.0000 | 1,262,000,000 | 3.99% | 0.00% |
| Feb. 28, 2025 | COWHEY THOMAS F. | EVP and CFO | F | Common Stock | 5318 | $65.72 | 45,256.0000 | 1,262,000,000 | 10.52% | 0.00% |
| Feb. 28, 2025 | Khichi Samrat S. | EVP, CPO and General Counsel | F | Common Stock | 5604 | $65.72 | 20,106.0000 | 1,262,000,000 | 21.80% | 0.00% |
| Feb. 18, 2025 | Mahoney Michael F | Director | P | Common Stock (By Trust) | 30000 | $66.70 | 39,566.0000 | 1,262,000,000 | 313.61% | 0.00% |
| Nov. 30, 2024 | Joyner J. David | President and CEO | A | Premium Stock Appreciation Right | 492537 | $71.82 | 492,537.0000 | 1,262,000,000 | 9999.99% | 0.04% |
| Nov. 30, 2024 | Joyner J. David | President and CEO | A | Premium Stock Option | 1000000 | $71.82 | 1,000,000.0000 | 1,262,000,000 | 9999.99% | 0.08% |
| Dec. 5, 2024 | Finucane Anne A. | Director | G | Common Stock | 2665 | $56.86 | 29,765.2482 | 1,262,000,000 | 8.22% | 0.00% |
| Nov. 30, 2024 | Shah Prem S | EVP and Group President | A | Premium Stock Option | 746268 | $71.82 | 746,268.0000 | 1,262,000,000 | 9999.99% | 0.06% |
| Nov. 30, 2024 | Joyner J. David | President and CEO | A | Premium Stock Option | 1492537 | $71.82 | 1,492,537.0000 | 1,262,000,000 | 9999.99% | 0.12% |
| Nov. 30, 2024 | Clark James David | SVP, Cont & Chief Acct Officer | F | Common Stock | 86 | $59.85 | 8,394.0000 | 1,262,000,000 | 1.01% | 0.00% |
| Nov. 30, 2024 | FARAH ROGER N | Director | A | Common Stock (Restricted) | 50125 | $59.85 | 50,125.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| Nov. 30, 2024 | CAPOZZI HEIDI B | EVP and Chief People Officer | A | Common Stock (Restricted) | 83542 | $59.85 | 83,542.0000 | 1,262,000,000 | 9999.99% | 0.01% |
| Nov. 30, 2024 | Nelson Steven H | EVP and President, Aetna | A | Premium Stock Option | 124378 | $71.82 | 124,378.0000 | 1,262,000,000 | 9999.99% | 0.01% |
| Nov. 30, 2024 | Mandadi Tilak | EVP, Chief DDAT Officer | A | Common Stock (RSU) | 50125 | $59.85 | 99,747.0000 | 1,262,000,000 | 101.01% | 0.00% |
| Nov. 21, 2024 | ROBBINS LARRY | Director | A | Deferred Stock Units | 2933 | $57.10 | 2,933.4501 | 1,262,000,000 | 9999.99% | 0.00% |
| Nov. 21, 2024 | AGUIRRE FERNANDO | Director | A | Common Stock | 2364 | $57.10 | 37,555.0000 | 1,262,000,000 | 6.72% | 0.00% |
| Nov. 21, 2024 | Balser Jeffrey R. | Director | A | Common Stock | 2375 | $57.10 | 9,652.0000 | 1,262,000,000 | 32.64% | 0.00% |
| Nov. 21, 2024 | BROWN C DAVID II | Director | A | Common Stock | 2331 | $57.10 | 123,765.0000 | 1,262,000,000 | 1.92% | 0.00% |
| Nov. 21, 2024 | DECOUDREAUX ALECIA A | Director | A | Deferred Stock Units | 2200 | $57.10 | 34,934.2665 | 1,262,000,000 | 6.72% | 0.00% |
| Nov. 21, 2024 | DEPARLE NANCY ANN | Director | A | Common Stock | 2331 | $57.10 | 34,169.0000 | 1,262,000,000 | 7.32% | 0.00% |
| Nov. 21, 2024 | Finucane Anne A. | Director | A | Deferred Stock Units | 2200 | $57.10 | 12,173.1640 | 1,262,000,000 | 22.06% | 0.00% |
| Nov. 21, 2024 | KIRBY J SCOTT | Director | A | Common Stock | 2933 | $57.10 | 8,566.0000 | 1,262,000,000 | 52.07% | 0.00% |
| Nov. 21, 2024 | Mahoney Michael F | Director | A | Common Stock | 2200 | $57.10 | 6,201.0000 | 1,262,000,000 | 54.99% | 0.00% |
| Nov. 21, 2024 | MILLON JEAN PIERRE | Director | A | Common Stock | 2200 | $57.10 | 112,217.0000 | 1,262,000,000 | 2.00% | 0.00% |
| Nov. 21, 2024 | SCHAPIRO MARY L | Director | A | Deferred Stock Units | 2933 | $57.10 | 24,436.9156 | 1,262,000,000 | 13.64% | 0.00% |
| Nov. 21, 2024 | Norwalk Leslie V | Director | A | Common Stock | 2200 | $57.10 | 2,200.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| Nov. 21, 2024 | SANSONE GUY P | Director | A | Common Stock | 2200 | $57.10 | 8,360.3550 | 1,262,000,000 | 35.71% | 0.00% |
| Nov. 21, 2024 | Shulman Douglas H. | Director | A | Common Stock | 2200 | $57.10 | 2,200.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| Aug. 31, 2024 | Mandadi Tilak | EVP, Chief Technology Officer | F | Common Stock | 13097 | $57.24 | 40,414.0000 | 1,290,000,000 | 24.48% | 0.00% |
| May 16, 2024 | AGUIRRE FERNANDO | Director | A | Common Stock | 2347 | $57.52 | 35,191.0000 | 1,290,000,000 | 7.15% | 0.00% |
| May 16, 2024 | Balser Jeffrey R. | Director | A | Common Stock | 2184 | $57.52 | 7,277.0000 | 1,290,000,000 | 42.88% | 0.00% |
| May 16, 2024 | BROWN C DAVID II | Director | A | Common Stock | 2314 | $57.52 | 121,434.0000 | 1,290,000,000 | 1.94% | 0.00% |
| May 16, 2024 | DECOUDREAUX ALECIA A | Director | A | Share Credits | 2184 | $57.52 | 31,994.3033 | 1,290,000,000 | 7.33% | 0.00% |
| May 16, 2024 | SCHAPIRO MARY L | Director | A | Share Credits | 2912 | $57.52 | 21,017.4328 | 1,290,000,000 | 16.08% | 0.00% |
| May 16, 2024 | Mahoney Michael F | Director | A | Common Stock | 2184 | $57.52 | 4,001.0000 | 1,290,000,000 | 120.20% | 0.00% |
| May 16, 2024 | MILLON JEAN PIERRE | Director | A | Common Stock | 2314 | $57.52 | 110,017.0000 | 1,290,000,000 | 2.15% | 0.00% |
| May 16, 2024 | DEPARLE NANCY ANN | Director | A | Common Stock | 2314 | $57.52 | 31,838.0000 | 1,290,000,000 | 7.84% | 0.00% |
| May 16, 2024 | FARAH ROGER N | Director | A | Share Credits | 5303 | $57.52 | 35,561.3323 | 1,290,000,000 | 17.52% | 0.00% |
| May 16, 2024 | Finucane Anne A. | Director | A | Share Credits | 2184 | $57.52 | 9,747.6598 | 1,290,000,000 | 28.88% | 0.00% |
| May 16, 2024 | KIRBY J SCOTT | Director | A | Common Stock | 2912 | $57.52 | 5,633.0000 | 1,290,000,000 | 107.02% | 0.00% |
| May 2, 2024 | Mahoney Michael F | Director | P | Common Stock (By Trust) | 9181 | $54.49 | 9,566.0000 | 1,290,000,000 | 2384.68% | 0.00% |
| May 2, 2024 | LUDWIG EDWARD J | Director | P | Common Stock | 1000 | $53.88 | 32,709.0000 | 1,290,000,000 | 3.15% | 0.00% |
| April 1, 2024 | Khichi Samrat S. | EVP, CPO and General Counsel | A | Common Stock (Restricted) | 12569 | $0.00 | 44,490.0000 | 1,290,000,000 | 39.38% | 0.00% |
| April 1, 2024 | Kane Brian A | EVP/President, Aetna | A | Stock Option | 52246 | $79.56 | 52,246.0000 | 1,290,000,000 | 9999.99% | 0.00% |
| April 1, 2024 | Kane Brian A | EVP/President, Aetna | A | Common Stock (Restricted) | 12569 | $0.00 | 12,569.0000 | 1,290,000,000 | 9999.99% | 0.00% |
| April 1, 2024 | Joyner J. David | EVP&President-PharmacyServices | A | Common Stock (Restricted) | 28280 | $0.00 | 44,241.0000 | 1,290,000,000 | 177.18% | 0.00% |
| April 1, 2024 | Havanec Laurie P. | EVP and Chief People Officer | A | Stock Option | 39184 | $79.56 | 39,184.0000 | 1,290,000,000 | 9999.99% | 0.00% |
| April 1, 2024 | Havanec Laurie P. | EVP and Chief People Officer | F | Common Stock | 7630 | $79.56 | 37,553.0000 | 1,290,000,000 | 16.89% | 0.00% |
| April 1, 2024 | Chaguturu Sreekanth K | EVP and Chief Medical Officer | A | Stock Option | 28735 | $79.56 | 28,735.0000 | 1,290,000,000 | 9999.99% | 0.00% |
| April 1, 2024 | Chaguturu Sreekanth K | EVP and Chief Medical Officer | A | Common Stock (Restricted) | 6913 | $79.56 | 23,666.0000 | 1,290,000,000 | 41.26% | 0.00% |
| April 1, 2024 | Chaguturu Sreekanth K | EVP and Chief Medical Officer | F | Common Stock | 825 | $79.56 | 11,211.9847 | 1,290,000,000 | 6.85% | 0.00% |
| April 1, 2024 | Chaguturu Sreekanth K | EVP and Chief Medical Officer | F | Common Stock | 1473 | $79.56 | 12,036.9847 | 1,290,000,000 | 10.90% | 0.00% |
| April 1, 2024 | Clark James David | SVP, Cont & Chief Acct Officer | A | Common Stock (Restricted) | 10683 | $79.56 | 15,109.0000 | 1,290,000,000 | 241.37% | 0.00% |
| April 1, 2024 | Clark James David | SVP, Cont & Chief Acct Officer | F | Common Stock | 1112 | $79.56 | 8,480.0000 | 1,290,000,000 | 11.59% | 0.00% |
| April 1, 2024 | Havanec Laurie P. | EVP and Chief People Officer | A | Common Stock (Restricted) | 9426 | $79.56 | 9,426.0000 | 1,290,000,000 | 9999.99% | 0.00% |
| April 1, 2024 | Lynch Karen S | President and CEO | A | Stock Option | 188087 | $79.56 | 188,087.0000 | 1,290,000,000 | 9999.99% | 0.01% |
| April 1, 2024 | Lynch Karen S | President and CEO | F | Common Stock | 61953 | $79.56 | 74,687.0000 | 1,290,000,000 | 45.34% | 0.00% |
| April 1, 2024 | Lynch Karen S | President and CEO | A | Common Stock (Restricted) | 45248 | $79.56 | 45,248.0000 | 1,290,000,000 | 9999.99% | 0.00% |
| April 1, 2024 | Mandadi Tilak | EVP, Chief Technology Officer | A | Stock Option | 67920 | $79.56 | 67,920.0000 | 1,290,000,000 | 9999.99% | 0.01% |
| April 1, 2024 | Mandadi Tilak | EVP, Chief Technology Officer | A | Common Stock (RSU) | 16339 | $0.00 | 82,904.0000 | 1,290,000,000 | 24.55% | 0.00% |
| April 1, 2024 | Shah Prem S | EVP and Pres-Pharm, Consumer W | A | Stock Option | 62695 | $79.56 | 62,695.0000 | 1,290,000,000 | 9999.99% | 0.00% |
| April 1, 2024 | Shah Prem S | EVP and Pres-Pharm, Consumer W | A | Common Stock (Restricted) | 15082 | $0.00 | 37,057.0000 | 1,290,000,000 | 68.63% | 0.00% |
| April 1, 2024 | Shah Prem S | EVP and Pres-Pharm, Consumer W | F | Common Stock | 5239 | $79.56 | 42,034.4630 | 1,290,000,000 | 11.08% | 0.00% |
| April 1, 2024 | Shah Prem S | EVP and Pres-Pharm, Consumer W | F | Common Stock | 2653 | $79.56 | 47,273.4630 | 1,290,000,000 | 5.31% | 0.00% |
| April 1, 2024 | COWHEY THOMAS F. | EVP and CFO | A | Stock Option | 62695 | $79.56 | 62,695.0000 | 1,290,000,000 | 9999.99% | 0.00% |
| April 1, 2024 | COWHEY THOMAS F. | EVP and CFO | A | Common Stock (Restricted) | 15082 | $0.00 | 47,995.0000 | 1,290,000,000 | 45.82% | 0.00% |
| April 1, 2024 | COWHEY THOMAS F. | EVP and CFO | F | Common Stock | 1719 | $79.56 | 35,642.0000 | 1,290,000,000 | 4.60% | 0.00% |
| April 1, 2024 | Khichi Samrat S. | EVP, CPO and General Counsel | A | Stock Option | 52246 | $79.56 | 52,246.0000 | 1,290,000,000 | 9999.99% | 0.00% |
| April 1, 2024 | Clark James David | SVP, Cont & Chief Acct Officer | F | Common Stock | 1892 | $79.56 | 9,592.0000 | 1,290,000,000 | 16.48% | 0.00% |
| Feb. 28, 2024 | Khichi Samrat S. | EVP, CPO and General Counsel | F | Common Stock | 6210 | $75.19 | 9,750.0000 | 1,290,000,000 | 38.91% | 0.00% |
| Feb. 28, 2024 | Joyner J. David | EVP&President-PharmacyServices | F | Common Stock | 1970 | $75.19 | 40,681.0000 | 1,290,000,000 | 4.62% | 0.00% |
| Feb. 28, 2024 | COWHEY THOMAS F. | SVP, Interim CFO | F | Common Stock | 5641 | $75.19 | 28,631.0000 | 1,290,000,000 | 16.46% | 0.00% |
| Feb. 26, 2024 | Havanec Laurie P. | EVP and Chief People Officer | F | Common Stock | 6698 | $76.43 | 45,183.0000 | 1,290,000,000 | 12.91% | 0.00% |
| Feb. 26, 2024 | Shah Prem S | EVP and Pres-Pharm, Consumer W | F | Common Stock | 261 | $76.43 | 43,185.4630 | 1,290,000,000 | 0.60% | 0.00% |
| Feb. 26, 2024 | Chaguturu Sreekanth K | EVP and Chief Medical Officer | F | Common Stock | 355 | $76.43 | 9,333.9847 | 1,290,000,000 | 3.66% | 0.00% |
| Feb. 16, 2024 | Shah Prem S | EVP and Pres-Pharm, Consumer W | S | Common Stock | 29473 | $76.95 | 39,764.7624 | 1,290,000,000 | 42.57% | 0.00% |
| Feb. 12, 2024 | Havanec Laurie P. | EVP and Chief People Officer | A | Common Stock | 16817 | $0.00 | 37,203.0000 | 1,290,000,000 | 82.49% | 0.00% |
| Feb. 12, 2024 | Clark James David | SVP, Cont & Chief Acct Officer | A | Common Stock | 2452 | $0.00 | 7,150.0000 | 1,290,000,000 | 52.19% | 0.00% |
| Feb. 12, 2024 | Shah Prem S | EVP and Pres-Pharm, Consumer W | A | Common Stock | 13313 | $0.00 | 69,237.7624 | 1,290,000,000 | 23.81% | 0.00% |
| Feb. 12, 2024 | Lynch Karen S | President and CEO | A | Common Stock | 136640 | $0.00 | 136,640.0000 | 1,290,000,000 | 9999.99% | 0.01% |
| Feb. 12, 2024 | Chaguturu Sreekanth K | EVP and Chief Medical Officer | A | Common Stock | 1926 | $0.00 | 8,645.1867 | 1,290,000,000 | 28.66% | 0.00% |